ImmunityBio (IBRX) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.30% |
| Dec 31, 2025 | -30.17% |
| Sep 30, 2025 | -31.32% |
| Jun 30, 2025 | -21.53% |
| Mar 31, 2025 | 32.16% |
| Dec 31, 2024 | 22.43% |
| Sep 30, 2024 | -16.50% |
| Jun 30, 2024 | -27.54% |
| Mar 31, 2024 | -26.95% |
| Dec 31, 2023 | -40.97% |
| Sep 30, 2023 | -8.92% |
| Jun 30, 2023 | 26.43% |
| Mar 31, 2023 | -4.69% |
| Dec 31, 2022 | 0.68% |
| Sep 30, 2022 | -83.73% |
| Jun 30, 2022 | -0.41% |
| Mar 31, 2022 | -102.25% |
| Dec 31, 2021 | -162.92% |
| Sep 30, 2021 | 0.60% |
| Jun 30, 2021 | 0.12% |
| Mar 31, 2021 | 12.06% |
| Dec 31, 2020 | 9.58% |
| Sep 30, 2020 | 0.32% |
| Jun 30, 2020 | 11.15% |
| Mar 31, 2020 | 24.58% |
| Dec 31, 2019 | 17.44% |
| Sep 30, 2019 | 55.62% |
| Jun 30, 2019 | 26.74% |
| Mar 31, 2019 | 52.69% |
| Dec 31, 2018 | 60.93% |
| Sep 30, 2018 | 38.53% |
| Jun 30, 2018 | 4.49% |
| Mar 31, 2018 | -34.68% |
| Dec 31, 2017 | -29.43% |
| Sep 30, 2017 | -259.31% |
| Jun 30, 2017 | -252.94% |
| Dec 31, 2016 | -728.33% |